Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Videos | TCT

DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies ...

Home November 05, 2015
Home
Videos | TCT

Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...

Home November 05, 2015
Home
News | Left Atrial Appendage (LAA) Occluders

October 28, 2015 — SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial ...

Home October 28, 2015
Home
News | Heart Valve Technology

October 27, 2015 — A large observational registry found that initial aortic valve replacement (AVR) in asymptomatic ...

Home October 27, 2015
Home
News | Heart Valve Technology

October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that ...

Home October 22, 2015
Home
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies

October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...

Home October 20, 2015
Home
Amaranth Fortitute Bioresorbable stent
Feature | TCT | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...

Home October 19, 2015
Home
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke
Feature | Stroke

October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with ...

Home October 16, 2015
Home
Claret embolic protection, TAVR, cerebral protection
Feature | Heart Valve Technology

October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at ...

Home October 16, 2015
Home
News | Heart Valve Technology

October 15, 2015 — Edwards Lifesciences Corp. announced that details on the 13 first-in-human compassionate use cases wi ...

Home October 15, 2015
Home
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results
Feature | Heart Valve Technology

October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with ...

Home October 15, 2015
Home
Technology | Heart Valve Technology

October 15, 2015 — U.S. Food and Drug Administration (FDA) has cleared Edwards Lifesciences Sapien XT transcatheter ...

Home October 15, 2015
Home
News | Heart Valve Technology

October 14, 2015 — Boston Scientific Corp. announced it has closed on an additional round of financing with MValve ...

Home October 14, 2015
Home
News | Heart Valve Technology

September 18, 2015 — St. Jude Medical Inc. announced European CE Mark approval for the 27mm and 29mm Portico transcathet ...

Home September 18, 2015
Home
Subscribe Now